LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

Search

Baxter International Inc

Cerrado

Sector Salud

39.76 -1.27

Resumen

Variación precio

24h

Actual

Mínimo

39.66

Máximo

40.4

Métricas clave

By Trading Economics

Ingresos

-351M

-314M

Ventas

3.8B

3.8B

P/B

Media del Sector

604.629

102.974

BPA

0.68

Margen de beneficio

-8.241

Empleados

60,000

EBITDA

-419M

135M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+4.82 upside

Dividendos

By Dow Jones

Próximas Ganancias

31 oct 2024

Fecha Próximo Dividendo

1 oct 2024

Próxima Fecha de Ex Dividendo

28 nov 2024

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

963M

20B

Apertura anterior

41.03

Cierre anterior

39.76

Noticias sobre sentimiento de mercado

By Acuity

23%

77%

40 / 366 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Baxter International Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

27 mar 2024, 21:59 UTC

Adquisiciones, fusiones, absorciones

3M's Healthcare Spinoff Stock Fell. This Is What It's Worth. -- Barrons.com

27 mar 2024, 09:15 UTC

Adquisiciones, fusiones, absorciones

3M's Healthcare Spinoff Stock Is Trading. This Is What It's Worth. -- Barrons.com

Comparación entre iguales

Cambio de precio

Baxter International Inc Esperado

Precio Objetivo

By TipRanks

4.82% repunte

Estimación a 12 meses

Media 42.2 USD  4.82%

Máximo 54 USD

Mínimo 30 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Baxter International Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

12 ratings

3

Comprar

8

Mantener

1

Vender

Puntuación técnica

By Trading Central

39.48 / N/ASoporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

40 / 366 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Baxter International Inc

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.